Group One Trading, L.P. Gossamer Bio, Inc. Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 207,744 shares of GOSS stock, worth $240,983. This represents 0.01% of its overall portfolio holdings.
Number of Shares
207,744
Previous 74,644
178.31%
Holding current value
$240,983
Previous $67,000
240.3%
% of portfolio
0.01%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding GOSS
# of Institutions
127Shares Held
162MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$21.3 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$21 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$11.7 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$9.34 Million7.27% of portfolio
-
Acadian Asset Management LLC Boston, MA6.36MShares$7.38 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $109M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...